Navigation Links
Use of Statin can help in recovery from stroke

Use of statins before or after an ischemic stroke can improve the rate of recovery for the patients. Patients who had statin before stroke have a chance of 1.6 times more of // having a favorable recovery than persons who have not been exposed to statins. People who were on statins after the stroke had the chance of 2.6 times more of a favorable recovery than others.

The study had looked into 1618 people who had ischemic stroke to assess the usefulness of statins before or after the stroke on the rate of recovery.

Statins are a group of drugs that are used to reduce cholesterol. They affect the liver to stop producing a chemical that makes cholesterol. They also allow the body to absorb the cholesterol that had been accumulated in plaques of the artery walls. Statins have many side effects; long-term use of them may reduce the existing blockage of the blood vessels.

Statins, in stroke patients, reduces C-reactive protein, improve the endothelium and have an anti-clotting effect.

The results were presented in the American Academy of Neurology 57th Annual Meeting, held in Miami, US recently.

Reference: American Academy of Neurology 57th Annual Meeting, April 2005


'"/>




Page: 1

Related medicine news :

1. Statins reduce heart attacks
2. Statins reduce risks for angioplasty patients
3. Statins Found To Be Helpful For Patients With Arthritis
4. Long-Term Benefits Of Statins Questioned
5. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
6. Statins Not Effective In Treating Calcific Aortic Stenosis
7. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
8. The Effects of Statins Questioned
9. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
10. Study Finds No Link Between Statins And Breast Cancer Risk
11. Statins Reduce Deaths And Strokes After Carotid Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: